Literature DB >> 20029045

Mislocalization of SLP-76 leads to aberrant inflammatory cytokine and autoantibody production.

Gregory F Sonnenberg1, Paul R Mangan, Natalie A Bezman, Debora R Sekiguchi, Eline T Luning Prak, Jan Erikson, Jonathan S Maltzman, Martha S Jordan, Gary A Koretzky.   

Abstract

Central and peripheral tolerance is required to prevent immune responses to self-antigens. We now present a mouse model in which wild-type (WT) SH2 domain-containing leukocyte phosphoprotein of 76 kDa (SLP-76) has been constitutively targeted to the membrane, where CD4+ T cells become spontaneously dysregulated and develop an inflammatory phenotype. Mice bearing membrane-targeted SLP-76 (MTS) have a partial T-cell lymphopenia and impaired signaling though the mature T-cell receptor. The CD4+ T cells that develop in these mice possess an activated-like phenotype and are skewed toward the inflammatory T(H)1 and T(H)17 lineages. MTS mice also spontaneously develop autoantibodies at an early age. To rule out abnormal thymic selection as the sole cause of the MTS phenotype, we expressed WT SLP-76 along with the MTS followed by deletion of the WT allele in peripheral T cells. The peripheral MTS-expressing T cells demonstrate skewed cytokine responses when transferred into lymphopenic hosts. Thus, the abnormal effector T-cell phenotype still occurs in the presence of preserved central and peripheral tolerance, suggesting that diminished T-cell receptor signaling can promote skewed T-cell responses.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20029045      PMCID: PMC2920203          DOI: 10.1182/blood-2009-08-237438

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  52 in total

1.  Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.

Authors:  Estelle Bettelli; Yijun Carrier; Wenda Gao; Thomas Korn; Terry B Strom; Mohamed Oukka; Howard L Weiner; Vijay K Kuchroo
Journal:  Nature       Date:  2006-04-30       Impact factor: 49.962

Review 2.  SLP76 and SLP65: complex regulation of signalling in lymphocytes and beyond.

Authors:  Gary A Koretzky; Farhad Abtahian; Michael A Silverman
Journal:  Nat Rev Immunol       Date:  2006-01       Impact factor: 53.106

3.  Transforming growth factor-beta induces development of the T(H)17 lineage.

Authors:  Paul R Mangan; Laurie E Harrington; Darrell B O'Quinn; Whitney S Helms; Daniel C Bullard; Charles O Elson; Robin D Hatton; Sharon M Wahl; Trenton R Schoeb; Casey T Weaver
Journal:  Nature       Date:  2006-04-30       Impact factor: 49.962

4.  The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3.

Authors:  C L Bennett; J Christie; F Ramsdell; M E Brunkow; P J Ferguson; L Whitesell; T E Kelly; F T Saulsbury; P F Chance; H D Ochs
Journal:  Nat Genet       Date:  2001-01       Impact factor: 38.330

Review 5.  Autoimmunity during lymphopenia: a two-hit model.

Authors:  Tom Krupica; Terry J Fry; Crystal L Mackall
Journal:  Clin Immunol       Date:  2006-08       Impact factor: 3.969

Review 6.  Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease.

Authors:  Shimon Sakaguchi; Masahiro Ono; Ruka Setoguchi; Haruhiko Yagi; Shohei Hori; Zoltan Fehervari; Jun Shimizu; Takeshi Takahashi; Takashi Nomura
Journal:  Immunol Rev       Date:  2006-08       Impact factor: 12.988

7.  TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells.

Authors:  Marc Veldhoen; Richard J Hocking; Christopher J Atkins; Richard M Locksley; Brigitta Stockinger
Journal:  Immunity       Date:  2006-02       Impact factor: 31.745

8.  Conditional deletion reveals a cell-autonomous requirement of SLP-76 for thymocyte selection.

Authors:  Jonathan S Maltzman; Lisa Kovoor; James L Clements; Gary A Koretzky
Journal:  J Exp Med       Date:  2005-09-26       Impact factor: 14.307

9.  Mutation of the phospholipase C-gamma1-binding site of LAT affects both positive and negative thymocyte selection.

Authors:  Connie L Sommers; Jan Lee; Kevin L Steiner; Jordan M Gurson; Corinne L Depersis; Dalal El-Khoury; Claudette L Fuller; Elizabeth W Shores; Paul E Love; Lawrence E Samelson
Journal:  J Exp Med       Date:  2005-03-28       Impact factor: 14.307

10.  LAT-mediated signaling in CD4+CD25+ regulatory T cell development.

Authors:  Surapong Koonpaew; Shudan Shen; Lawrence Flowers; Weiguo Zhang
Journal:  J Exp Med       Date:  2005-12-27       Impact factor: 14.307

View more
  7 in total

1.  Quantitative reduction of the TCR adapter protein SLP-76 unbalances immunity and immune regulation.

Authors:  Owen M Siggs; Lisa A Miosge; Stephen R Daley; Kelly Asquith; Paul S Foster; Adrian Liston; Christopher C Goodnow
Journal:  J Immunol       Date:  2015-02-06       Impact factor: 5.422

2.  Posttranscriptional silencing of effector cytokine mRNA underlies the anergic phenotype of self-reactive T cells.

Authors:  Alejandro V Villarino; Shoshana D Katzman; Eugenio Gallo; Omer Miller; Shuwei Jiang; Michael T McManus; Abul K Abbas
Journal:  Immunity       Date:  2011-01-13       Impact factor: 31.745

3.  Understanding signal integration through targeted mutations of an adapter protein.

Authors:  Tao Zou; Rebecca M May; Gary A Koretzky
Journal:  FEBS Lett       Date:  2010-10-21       Impact factor: 4.124

4.  T-cell receptor signals direct the composition and function of the memory CD8+ T-cell pool.

Authors:  Jennifer E Smith-Garvin; Jeremy C Burns; Mercy Gohil; Tao Zou; Jiyeon S Kim; Jonathan S Maltzman; E John Wherry; Gary A Koretzky; Martha S Jordan
Journal:  Blood       Date:  2010-09-16       Impact factor: 22.113

5.  Distinct requirements of microRNAs in NK cell activation, survival, and function.

Authors:  Natalie A Bezman; Elizabeth Cedars; David F Steiner; Robert Blelloch; David G T Hesslein; Lewis L Lanier
Journal:  J Immunol       Date:  2010-08-30       Impact factor: 5.422

6.  Pak2 Links TCR Signaling Strength to the Development of Regulatory T Cells and Maintains Peripheral Tolerance.

Authors:  Kyle Leonard O'Hagan; Jinyong Choi; Olga Pryshchep; Jonathan Chernoff; Hyewon Phee
Journal:  J Immunol       Date:  2015-07-08       Impact factor: 5.422

7.  A novel prognostic biomarker LCP2 correlates with metastatic melanoma-infiltrating CD8+ T cells.

Authors:  Zijun Wang; Mou Peng
Journal:  Sci Rep       Date:  2021-04-28       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.